Adma Biologics (ADMA) Interest Coverage Ratio (2011 - 2025)
Adma Biologics (ADMA) reported Interest Coverage Ratio of 38.59 for Q4 2025, up 189.92% on a YoY basis from 13.31 in Q4 2024, and up 26.72% quarter-over-quarter from 30.45 in Q3 2025.
Adma Biologics (ADMA) Interest Coverage Ratio (2011 - 2025) Analysis & Trends
Adma Biologics has reported Interest Coverage Ratio for 13 years, with the latest figure at 38.59 in Q4 2025.
- For the quarter ending Q4 2025, Interest Coverage Ratio rose 189.92% year-over-year to 38.59; the trailing twelve-month figure through Dec 2025 stood at 26.93 (up 169.87% YoY), and the FY2025 full-year result was 26.93, up 169.87% from the prior year.
- Interest Coverage Ratio for Q4 2025 stood at 38.59, up from 30.45 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 38.59 in Q4 2025, with the low at 4.8 in Q2 2021.
- Historically, Interest Coverage Ratio has averaged 6.36 across 5 years, with a median of 0.64 in 2023.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio advanced 1.97% — and 2024, when it jumped 13899.75%.
- Adma Biologics' Interest Coverage Ratio stood at 3.98 in 2021, then jumped by 73.45% to 1.06 in 2022, then soared by 316.84% to 2.29 in 2023, then surged by 481.25% to 13.31 in 2024, then soared by 189.92% to 38.59 in 2025.
- The last three Interest Coverage Ratio figures came in at 38.59 (Q4 2025), 30.45 (Q3 2025), and 23.34 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn | 38.59 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 38.59 |
| Sep 30, 2025 | 30.45 |
| Jun 30, 2025 | 23.34 |
| Mar 31, 2025 | 17.66 |
| Dec 31, 2024 | 13.31 |
| Sep 30, 2024 | 11.33 |
| Jun 30, 2024 | 10.36 |
| Mar 31, 2024 | 5.79 |
| Dec 31, 2023 | 2.29 |
| Sep 30, 2023 | 1.36 |
| Jun 30, 2023 | -0.08 |
| Mar 31, 2023 | -0.13 |
| Dec 31, 2022 | -1.06 |
| Sep 30, 2022 | -1.67 |
| Jun 30, 2022 | -2.01 |
| Mar 31, 2022 | -4.37 |
| Dec 31, 2021 | -3.98 |
| Sep 30, 2021 | -4.38 |
| Jun 30, 2021 | -4.80 |
| Mar 31, 2021 | -4.75 |